about
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of ...
Read More
18.66
-0.22
(-1.17%)
37.9M
XNYS Volume
XNYS 19 Feb, 2026 4:30 PM (EST)
Layoff
Kenvue to cut 3.5% of its workforce to cut costs ahead of its planned acquisition by Kimberly-Clark
See details
High Financial Strength
Mid Valuation
Technically Neutral
Mid-range Performer
These stocks have strong quality. Their reasonable financials and technicals make them potentially attractive to investors
View Similar
Embed DVM
Kenvue Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..